Biodesix $55 million follow-on offering
The common stock is listed on the Nasdaq Global Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Adagene $100 million at-the-market offering
We advised Adagene on the offering
LianLian DigiTech HK$657 million IPO
We advised Lianlian DigiTech on its IPO and HKEX listing
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
JPMorgan Chase €2 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Smith+Nephew $1 billion notes offering
We advised the issuer on the SEC-registered offering
Tellurian $366.1 million at-the-market offering
The shares are listed on the NYSE
Trial Holdings ¥44.6 billion IPO
The shares are listed on the Tokyo Stock Exchange
BBVA $2 billion senior notes offering
We advised BBVA on its offering of senior preferred fixed-rate notes and senior non-preferred fixed-to-fixed-rate notes
Banco Santander $4 billion notes offering
We advised Banco Santander on the notes due 2028, 2030 and 2034